Bellicum, Astellas Announce License Agreement for Cancer Target PSCA in Cell and Gene Therapy

By: via Benzinga
Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM) and Astellas Pharma Inc. (OTC: ALPMY) today announced that Agensys, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.